V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280010643 | 280009324 | null | 68 | Palliative (P) | 2018-12-20 | 2018-12-24 | PEMBROLIZUMAB | N | N | 280030055 | VIDE |
| 280010644 | 280006355 | 1.6 | null | Palliative (P) | 2016-11-06 | 2016-12-19 | Cyclophosphamide PO +Vinorelbine IV | 2 | N | 280030057 | CARBO + FLUOROURACIL |
| 280010645 | 280006357 | 1.72 | 79.8 | Curative (C) | 2017-04-13 | 2017-04-30 | Capecitabine + Cisplatin | 2 | N | 280030059 | IFOSFAMIDE + VINCRISTINE |
| 280010646 | 280010749 | null | 64.2 | Palliative (P) | 2018-01-08 | 2018-01-16 | BCG Intravesical | 2 | null | 280030067 | CISPLATIN + FLUOROURACIL + RT |
| 280010647 | 280006362 | 1.8 | 50.6 | Palliative (P) | 2017-09-03 | 2017-09-03 | Cisplatin + Doxorubicin | N | N | 280030068 | CISPLATIN + FLUOROURACIL + RT |
| 280010648 | 280006363 | 1.83 | 76.9 | Neo-adjuvant (N) | 2018-03-24 | 2018-04-13 | CISPLATIN + FLUOROURACIL + RT | N | N | 280030068 | CARBO + FLUOROURACIL |
| 280010649 | 280006365 | 1.6 | 59.1 | Curative (C) | 2016-10-22 | 2016-10-22 | CARBOPLATIN + FLUOROURACIL | N | N | 280030073 | CHOP R |
| 280010650 | 280009332 | 1.71 | null | Adjuvant (A) | 2018-03-14 | 2018-03-22 | LIPOSOMAL DOXORUBICIN | null | null | 280030074 | BCG |
| 280010652 | 280006374 | 1.57 | 55 | Palliative (P) | 2015-11-19 | 2015-11-19 | Liposomal Doxorubicin 50mg/m2 | null | N | 280030100 | DACTINOMYCIN + CYCLO + VINCRISTINE |
| 280010653 | 280006376 | 1.6 | 68 | Neo-adjuvant (N) | 2018-02-09 | 2018-02-09 | CAPECITABINE + TEMOZOLOMIDE | 02 | null | 280030105 | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE |
| 280010654 | 280006377 | 1.65 | 18.18 | Disease modification (D) | 2016-02-05 | 2016-03-02 | Cyclophosphamide High Dose | N | N | 280030118 | METHOTREXATE INTRATHECAL |
| 280010655 | 280006378 | null | 84 | Palliative (P) | 2017-12-27 | 2018-04-15 | CARBOPLATIN + VINORELBINE | 2 | N | 280030120 | CARBOPLATIN + CETUXIMAB + FU |
| 280010656 | 280006380 | 1.75 | 79.8 | Adjuvant (A) | 2018-07-15 | 2019-01-09 | OCTREOTIDE | N | N | 280030124 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 280010657 | 280006382 | 1.8 | 84.5 | Curative (C) | 2017-04-04 | 2017-04-04 | IVADo | N | N | 280030134 | CYCLOPHOSPHAMIDE + DACTINOMYCIN + VINCRISTINE |
| 280010658 | 280006385 | 1.7 | 48.3 | Palliative (P) | 2015-05-19 | 2015-05-19 | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE | N | N | 280030152 | CISPLATIN + CYCLOPHOSPHAMIDE |
| 280010659 | 280006389 | null | 85.1 | Curative (C) | 2015-11-14 | 2016-03-05 | CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE + VINCRISTINE | null | Y | 280030163 | NIVOLUMAB |
| 280010660 | 280006394 | 1.72 | null | Palliative (P) | 2017-05-10 | 2017-05-27 | Capecitabine + Oxaliplatin 21day | null | null | 280030164 | ETOPOSIDE |
| 280010661 | 280006397 | 1.7 | null | null | 2017-04-22 | 2017-04-29 | VIA (Ifos 1.5g/m2) | N | N | 280030165 | ERLOTINIB |
| 280010662 | 280006398 | 1.6 | null | Neo-adjuvant (N) | 2017-01-04 | 2017-01-17 | Carboplatin + Pemetrexed | 02 | N | 280030167 | VINCRISTINE |
| 280010663 | 280011446 | 1.65 | null | Not known (9) | null | 2013-06-26 | Cyclophosphamide PO +Vinorelbine IV | N | N | 280030170 | CARBO + FLUOROURACIL |
| 280010664 | 280009346 | 1.8 | null | Curative (C) | 2018-12-13 | 2018-12-22 | Doxorubicin + Gemcitabine | N | N | 280030174 | MELPHALAN |
| 280010665 | 280009347 | 1.73 | 92 | Palliative (P) | 2015-07-20 | 2015-08-19 | VIDE | 2 | N | 280030176 | ENZALUTAMIDE |
| 280010666 | 280006403 | null | 61.5 | Palliative (P) | null | 2015-12-13 | OCTREOTIDE | N | N | 280030180 | ETOPOSIDE |
| 280010667 | 280006404 | 1.7 | 67 | null | 2016-01-31 | 2016-02-20 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL | Y | N | 280030184 | IRINOTECAN + VINCRISTINE |
| 280010668 | 280006406 | 1.83 | 71.1 | Curative (C) | 2015-03-23 | 2015-03-24 | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE | N | N | 280030187 | NIVOLUMAB |
| 280010669 | 280006408 | 1.67 | 64.1 | Palliative (P) | null | 2015-03-27 | Cyclophosphamide + Vincristine | N | N | 280030189 | BCG |
| 280010670 | 280006410 | 1.54 | 60.2 | Palliative (P) | 2016-09-25 | 2016-09-26 | Cyclophosphamide + Vincristine | 02 | N | 280030190 | MITOMYCIN INTRAVESICULAR |
| 280010671 | 280006414 | 1.81 | 61 | Palliative (P) | 2017-06-20 | 2017-06-20 | Pazopanib | 2 | N | 280030196 | VINCRISTINE |
| 280010672 | 280006416 | 1.85 | 84.6 | Palliative (P) | 2017-03-20 | 2017-03-23 | Gemcitabine + Capecitabine | N | N | 280030201 | DACARBAZINE |
| 280010673 | 280006418 | 1.71 | null | Palliative (P) | 2015-09-17 | 2016-01-08 | Cyclophosphamide + Topotecan | null | Y | 280030209 | PEMBROLIZUMAB |
| 280010674 | 280006420 | 1.78 | null | Palliative (P) | 2013-07-31 | 2013-08-13 | Capecitabine + Oxaliplatin 14day | N | N | 280030215 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 280010675 | 280006427 | 1.69 | 79.6 | Palliative (P) | 2018-03-28 | 2018-05-02 | VINCRISTINE | N | null | 280030221 | CAPECITABINE |
| 280010676 | 280006430 | 1.7 | null | Palliative (P) | 2015-01-10 | 2015-01-11 | Cyclophosphamide PO +Vinorelbine IV | 02 | N | 280030225 | AXI-STS TRIAL |
| 280010677 | 280006433 | null | 80.5 | null | 2014-09-29 | 2014-11-13 | Cyclophosphamide PO +Vinorelbine IV | N | N | 280030233 | MITOMYCIN INTRAVESICULAR |
| 280010678 | 280006436 | 1.54 | 56.8 | Palliative (P) | 2018-04-08 | 2018-04-16 | KESTREL Trial | null | null | 280030257 | IVADO |
| 280010679 | 280006438 | null | 97 | Palliative (P) | 2013-09-20 | 2013-09-25 | VIDE | N | null | 280030261 | CHOP R |
| 280010680 | 280010764 | 1.66 | 66.6 | Palliative (P) | 2016-12-08 | 2016-12-08 | Bortezomib + Cyclophos + Dex | N | N | 280030265 | LIPOSOMAL DOXORUBICIN |
| 280010681 | 280006446 | 1.73 | 67.5 | Curative (C) | 2017-11-10 | 2018-03-30 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 280030274 | PAZOPANIB |
| 280010682 | 280006448 | 1.75 | 94.1 | Neo-adjuvant (N) | 2014-08-12 | 2014-12-02 | CARBOPLATIN + GEMCITABINE | N | N | 280030275 | SUNITINIB |
| 280010683 | 280010766 | 0 | 17.7 | Palliative (P) | 2017-11-07 | 2017-11-14 | TEMOZOLOMIDE | 02 | N | 280030279 | CARBOPLATIN + CETUXIMAB |
| 280010684 | 280006450 | null | 92 | Palliative (P) | 2013-11-17 | 2013-11-25 | Cyclophosphamide + Topotecan | 02 | N | 280030280 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 280010685 | 280009364 | 1.76 | 78.2 | Palliative (P) | 2013-11-06 | 2013-11-07 | Cyclophosphamide + Topotecan | 02 | N | 280030281 | PAZOPANIB |
| 280010686 | 280006452 | 1.54 | 68.9 | Disease modification (D) | 2017-05-06 | 2017-06-03 | Bevacizumab + Cape + Oxali 14day | N | N | 280030282 | EURAMOS TRIAL |
| 280010688 | 280006455 | 1.85 | 77.3 | Disease modification (D) | 2017-04-26 | 2017-05-04 | Bevacizumab 7.5mg/kg | N | N | 280030287 | BENDAMUSTINE + RITUXIMAB |
| 280010689 | 280009367 | 1.73 | 80.5 | Curative (C) | 2018-05-20 | 2018-06-20 | Vincristine (weekly) | 02 | N | 280030300 | VIDE |
| 280010690 | 280006460 | 1.62 | 47 | Palliative (P) | 2018-02-27 | 2018-02-27 | IVADo | 02 | N | 280030304 | CARBO + FLUOROURACIL |
| 280010691 | 280006462 | 1.68 | 63.75 | Neo-adjuvant (N) | 2017-08-29 | 2017-08-29 | Carboplatin + Cetux + FU (Cycle 1) | null | null | 280030312 | IRINOTECAN + VINCRISTINE |
| 280010692 | 280006465 | 2 | 66.9 | null | 2017-12-31 | 2018-02-14 | GEFITINIB | N | null | 280030329 | CISPLATIN + FLUOROURACIL + RT |
| 280010693 | 280006466 | 1.63 | 99.9 | Curative (C) | 2016-01-10 | 2016-03-01 | BLEOMYCIN + CISPLATIN + VINCRISTINE | 02 | null | 280030330 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 280010694 | 280010770 | 0 | 80.5 | null | 2015-08-01 | 2015-09-30 | CARBOPLATIN + FLUOROURACIL | 02 | N | 280030332 | CVP R |